SEARCH

SEARCH BY CITATION

References

  • 1
    McFarlane, D. (2007) Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease. Ageing Res. Rev. 6, 54-63.
  • 2
    McGowan, T.W., Pinchbeck, G.P. and McGowan, C.M. (2013) Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses. Equine Vet. J. 45, 74-79.
  • 3
    Couetil, L., Paradis, M.R. and Knoll, J. (1996) Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism. J. Vet. Intern. Med. 10, 1-6.
  • 4
    Van Der Kolk, J.H., Wensing, T., Kalsbeek, H.C. and Breukink, H.J. (1995) Laboratory diagnosis of equine pituitary pars intermedia adenoma. Domest. Anim. Endocrinol. 12, 35-39.
  • 5
    Perkins, G.A., Lamb, S., Erb, H.N., Schanbacher, B., Nydam, D.V. and Divers, T.J. (2002) Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide. Equine Vet. J. 34, 679-685.
  • 6
    Schott, H.I. (2002) Pituitary pars intermedia dysfunction: equine Cushing's disease. Vet. Clin. N. Am.: Equine Pract. 18, 237-270.
  • 7
    Divers, T. (2008) Pergolide and cyproheptadine: which medication to choose for treatment of equine Cushing's Disease? J. Equine Vet. Sci. 28, 370-371.
  • 8
    Dybdal, N.O., Hargreaves, K.M., Madigan, J.E., Gribble, D.H., Kennedy, P.C. and Stabenfeldt, G.H. (1994) Diagnostic testing for pituitary pars intermedia dysfunction in horses. J. Am. Vet. Med. Assoc. 204, 627-632.
  • 9
    Messer, N. and Johnson, P. (2007) Evidence-based literature pertaining to thyroid dysfunction and Cushing's Syndrome in the horse. Vet. Clin. N. Am.: Equine Pract. 23, 329-364.
  • 10
    Beech, J. and Garcia, M. (1995) Hormonal response to thyrotropin-releasing hormone in healthy horses and in horses with pituitary adenoma. Am. J. Vet. Res. 46, 1941-1943.
  • 11
    Beech, J., Boston, R., Lindborg, S. and Russell, G.E. (2007) Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia. J. Am. Vet. Med. Assoc. 231, 417-426.
  • 12
    Beech, J., McFarlane, D., Lindborg, S., Sojka, J.E. and Boston, R.C. (2011) α-Melanocyte-stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction. J. Am. Vet. Med. Assoc. 238, 1305-1315.
  • 13
    Divers, T. (2008) Endocrine testing in horses: metabolic syndrome and Cushing's Disease. J. Equine Vet. Sci. 28, 315-316.
  • 14
    Redekopp, C., Donald, R.A., Livesey, J.H., Sadler, W., Nicholls, M.G., Alexander, S.L. and Evans, M.J. (1986) Spontaneous and stimulated adrenocorticotropin and vasopressin pulsatile secretion in the pituitary venous effluent of the horse. Endocrinology 118, 1410-1416.
  • 15
    Irvine, C.H. and Alexander, S.L. (1987) A novel technique for measuring hypothalamic and pituitary hormone secretion rates from collection of pituitary venous effluent in the normal horse. J. Endocrinol. 113, 183-192.
  • 16
    Alexander, S.L., Irvine, C.H., Livesey, J.H. and Donald, R.A. (1988) Effect of isolation stress on concentrations of arginine vasopressin, alpha-melanocyte-stimulating hormone and ACTH in the pituitary venous effluent of the normal horse. J. Endocrinol. 116, 325-334.
  • 17
    Cudd, T.A., LeBlanc, M., Silver, M., Norman, W., Madison, J., Keller-Wood, M. and Wood, C.E. (1995) Ontogeny and ultradian rhythms of adrenocorticotropin and cortisol in the late-gestation fetal horse. J. Endocrinol. 144, 271-283.
  • 18
    Cordero, M., Brorsen, B.W. and McFarlane, D. (2012) Circadian and circannual rhythms of cortisol, ACTH, and α-melanocyte-stimulating hormone in healthy horses. Domest. Anim. Endocrinol. 43, 317-324.
  • 19
    Lee, Z.-Y., Zylstra, R. and Haritou, S.J.A. (2010) The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses. Vet. J. 185, 58-61.
  • 20
    Boujon, C.E., Bestetti, G.E., Meier, H.P., Straub, R., Junker, U. and Rossi, G.L. (1993) Equine pituitary adenoma: a functional and morphological study. J. Comp. Pathol. 109, 163-178.
  • 21
    Douglas, R. (1999) Circadian cortisol rhythmicity and equine Cushing's-like disease. J. Equine Vet. Sci. 19, 684-753.
  • 22
    McFarlane, D. (2011) Equine pituitary pars intermedia dysfunction. Vet. Clin. N. Am.: Equine Pract. 27, 93-113.
  • 23
    Miller, M.A., Pardo, I.D., Jackson, L.P., Moore, G.E. and Sojka, J.E. (2008) Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction. Vet. Pathol. 45, 26-38.
  • 24
    Heinrichs, M., Baumgärtner, W. and Capen, C.C. (1990) Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses. Vet. Pathol. 27, 419-425.
  • 25
    Okada, T., Shimomuro, T., Oikawa, M., Nambo, Y., Kiso, Y., Morikawa, Y., Liptrap, R.M., Yamashiro, S., Little, P.B. and Sasaki, F. (1997) Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in thoroughbreds. Am. J. Vet. Res. 58, 920-924.
  • 26
    Amann, J.F., Smith, R.M., Ganjam, V.K., Paull, W.K., McClure, R.C., Green, E.M. and Garner, H.E. (1987) Distribution and implications of beta-endorphin and ACTH-immunoreactive cells in the intermediate lobe of the hypophysis in healthy equids. Am. J. Vet. Res. 48, 323-327.
  • 27
    Copas, V.E.N. and Durham, A.E. (2011) Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction. Equine Vet. J. 44, 440-443.
  • 28
    McGowan, T.W., Pinchbeck, G.P. and McGowan, C.M. (2013) Evaluation of basal plasma α-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses. Equine Vet. J. 45, 66-73.